Planned surgical technique | Patient age, y | Pretreatment PSA level, ng/mL | Predicted functional erections after treatment, percent (95% CI) (by pretreatment sexual HRQOL score)* | ||
67 | 83 | 100 | |||
Nerve-sparing | 50 | ≤10 | 35 (25-45) | 52 (43-61) | 70 (61-77) |
>10 | 18 (9-34) | 32 (18-49) | 50 (32-68) | ||
60 | ≤10 | 23 (18-30) | 38 (33-44) | 57 (49-64) | |
>10 | 11 (0-21) | 21 (12-34) | 36 (22-53) | ||
70 | ≤10 | 15 (10-22) | 26 (19-35) | 43 (32-55) | |
>10 | 7 (3-14) | 13 (7-24) | 24 (13-41) | ||
Non–nerve-sparing | 50 | ≤10 | 13 (5-30) | 23 (9-46) | 39 (18-64) |
>10 | 6 (2-18) | 11 (4-31) | 21 (7-48) | ||
60 | ≤10 | 8 (3-19) | 14 (6-32) | 27 (12-50) | |
>10 | 3 (1-11) | 7 (2-19) | 13 (4-34) | ||
70 | ≤10 | 5 (2-12) | 9 (3-22) | 17 (7-37) | |
>10 | 2 (1-7) | 4 (1-12) | 8 (3-23) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟